Regulatory PathRegulatory requirements compared

Active substance

Clostridium botulinum neurotoxin a complex

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
BOTOX 100UNITS100 Upowder for solution for injection · Intramuscular use1 VialSAR 637.50Biological · PrescriptionABBVIE LIMITEDValid
SIAX50 UPowder for injection · Intramuscular use1 VialSAR 251.70Biological · PrescriptionMedytox Inc.Valid
SIAX100 UPowder for injection · Intramuscular use1 VialSAR 391.45Biological · PrescriptionMedytox Inc.Valid
SIAX200 UPowder for injection · Intramuscular use1 VialSAR 631.15Biological · PrescriptionMedytox Inc.Valid
BOTOX 200 UNIT200 Upowder for solution for injection · Intramuscular use1 VialSAR 1342.10Biological · PrescriptionALLERGAN PHARMACEUTICALS LTDWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

ANAL FISSURE; BELL'S PALSY; HEMORRHOIDS; HUNTINGTON'S DISEASE-DYSTONIA; MIGRAINE/ HEADACHE; RAYNAUD'S PHENOMENON; SPASTICITY; TOURETTE SYNDROME; URINARY INCONTINENCE AND OVERACTIVE BLADDER

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.